Microparticles during sepsis and trauma. A link between inflammation and thrombotic processes;Microparticules circulantes au cours des traumatismes graves et des sepsis : un élément du couplage inflammation-thrombose

Annales Francaises d'Anesthesie et de Reanimation

Volumn 25, Issue 9, 2006, Pages 955-966

  Morel, N ^a   Morel, O ^b,c,d   Delabranche, X ^c,d   Jesel, L ^b   Sztark, F ^a   Dabadie, P ^a   Freyssinet, J M ^c,d   Toti, F ^c,d  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d INSERM   (France)

Author keywords

Activation; Apoptosis; DIC; Endothelium; Selectins; Tissue factor

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ASCORBIC ACID; BLOOD CLOTTING FACTOR 7A; DROTRECOGIN; HEPARIN; ICOSAPENTAENOIC ACID; P SELECTIN GLYCOPROTEIN LIGAND 1; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

APOPTOSIS; BLOOD CLOTTING; CELL STIMULATION; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; INJURY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SEPSIS; SHORT SURVEY; THROMBOSIS; BIOLOGICAL MODEL; BLOOD; MONOCYTE; PATHOLOGY; REVIEW; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

APOPTOSIS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MODELS, CARDIOVASCULAR; MONOCYTES; SEPSIS; THROMBOSIS; WOUNDS AND INJURIES;

EID: 33748705131     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2006.04.013     Document Type: Short Survey

References (92)

1. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J. Thromb. Haemost. 1 (2003) 1655-1662
2. Aupeix K., Hugel B., Martin T., Bischoff P., Lill H., Pasquali J.L., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J. Clin. Invest. 99 (1997) 1546-1554
3. Jimenez J.J., Jy W., Mauro L.M., Soderland C., Horstman L.L., and Ahn Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb. Res. 109 (2003) 175-180
4. Perez-Casal M., Downey C., Fukudome K., Marx G., and Toh C.H. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood 105 (2005) 1515-1522 (Epub 2004 Oct 14)
5. Abid Hussein M.N., Meesters E.W., Osmanovic N., Romijn F.P., Nieuwland R., and Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J. Thromb. Haemost. 1 (2003) 2434-2443
6. Morel O., Hugel B., Jesel L., Zobairi F., Bareiss P., Freyssinet J.M., et al. Microparticules membranaires procoagulantes et complications athérothrombotiques chez le patient diabétique. Arch. Mal. Coeur Vaiss. 97 (2004) 1006-1012
7. Morel O., Ohlmann P., Morel N., Jesel L., Bareiss P., Freyssinet J.M., et al. Microparticules et pathologies cardiovasculaires. Perspectives thérapeutiques. Arch. Mal. Coeur Vaiss. 98 (2005) 236-241
8. Toti F., Satta N., Fressinaud E., Meyer D., and Freyssinet J.M. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87 (1996) 1409-1415
9. Hugel B., Socie G., Vu T., Toti F., Gluckman E., Freyssinet J.M., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 93 (1999) 3451-3456
10. Jy W., Horstmann L.L., Arce M., and Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J. Lab. Clin. Med. 119 (1992) 334-345
11. Morel O., Jesel L., Chauvin M., Freyssinet J.M., and Toti F. Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome. J. Thromb. Haemost. 1 (2003) 2685-2687
12. Biro E., Sturk-Maquelin K.N., Vogel G.M., Meuleman D.G., Smit M.J., Hack C.E., et al. Human-cell derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J. Thromb. Haemost. 1 (2003) 2561-2568
13. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P., Westendorp R.G., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95 (2000) 930-935
14. Geisbert T.W., Young H.A., Jahrling P.B., Davis K.J., Kagan E., and Hensley L.E. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J. Infect. Dis. 188 (2003) 1618-1629
15. Satta N., Freyssinet J.M., and Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br. J. Haematol. 96 (1997) 534-542
16. Satta N., Toti F., Feugeas O., Bohbot A., Dachary-Prigent J., Eschwege V., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J. Immunol. 153 (1994) 3245-3255
17. Freyssinet J.M., Toti F., Hugel B., Gidon-Jeangirard C., Kunzelmann C., Martinez M.C., et al. Apoptosis in vascular disease. Thromb. Haemost. 82 (1999) 727-735
18. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., et al. Role of tissue factor in embryonic cell development. Nature 383 (1996) 73-75
19. Doshi S.N., and Marmur J. Evolving role of tissue factor and its pathway inhibitor. Crit. Care Med. 30 (2002) S241-S250
20. Lopes-Bezerra L.M., and Filler S.G. Endothelial cells, tissue factor and infectious diseases. Braz. J. Med. Biol. Res. 36 (2003) 987-991
21. Bavendiek U., Libby P., Kilbride M., Reynolds R., Mackman N., and Schonbeck U. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J. Biol. Chem. 277 (2002) 25032-25039
22. Schonbeck U., Mach F., Sukhova G.K., Herman M., Graber P., Kehry M.R., et al. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am. J. Pathol. 156 (2000) 7-14
23. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., and Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 15 82 (1993) 513-520
24. Muller I., Klocke A., Alex M., Kotzsch M., Luther T., Morgenstern E., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 17 (2003) 476-478
25. Rauch U., and Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc. Med. 10 (2000) 139-143
26. Yu J.L., and Rak J.W. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J. Thromb. Haemost. 2 (2004) 2065-2067
27. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J. Exp. Med. 197 (2003) 1585-1598
28. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96 (2000) 170-175
29. Sabatier F., Roux V., Anfosso F., Camoin L., Sampol J., and Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99 (2002) 3962-3970
30. Scholz T., Temmler U., Krause S., Heptinstall S., and Losche W. Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb. Haemost. 88 (2002) 1033-1038
31. Osterud B. Tissue factor in neutrophils: no. J. Thromb. Haemost. 2 (2004) 218-220
32. Nakamura S., Imamura T., and Okamoto K. Tissue factor in neutrophils: yes. J. Thromb. Haemost. 2 (2004) 214-217
33. Morel O., Toti F., Hugel B., and Freyssinet J.M. Cellular microparticles: A disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11 (2004) 156-164
34. Shet A.S., Aras O., Gupta K., Hass M.J., Rausch D.J., Saba N., et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102 (2003) 2678-2683
35. Jimenez J.J., Jy W., Mauro L.M., Horstman L.L., Soderland C., and Ahn Y.S. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br. J. Haematol. 123 (2003) 896-902
36. Ogura H., Tanaka H., Koh T., Fujita K., Fujimi S., Nakamori Y., et al. Enhanced production of endothelial microparticles with increased binding to leucocytes in patients with severe systemic inflammatory response syndrome. J. Trauma 56 (2004) 823-830
37. Nooteboom A., van der Linden C.J., and Hendriks T. Modulation of adhesion molecule expression on endothelial cells after induction by lipopolysaccharide-stimulated whole blood. Scand. J. Immunol. 59 (2004) 440-448
38. Roldan V., Marin F., and Blann A. Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia. Blood Coagul. Fibrinolysis 15 (2004) 179-182
39. Orozco A.S., Zhou X., and Filler S.G. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect. Immun. 68 (2000) 1134-1141
40. Lopes-Bezerra L.M., and Filler S.G. Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity. Blood 103 (2004) 2143-2149
41. Dixon G.L., Heyderman R.S., van der Ley P., and Klein N.J. High-level endothelial E-selectin (CD62E) cell adhesion molecule expression by a lipopolysaccharide-deficient strain of Neisseria meningitidis despite poor activation of NF-kappaB transcription factor. Clin. Exp. Immunol. 135 (2004) 85-93
42. Metais C., Wiel E., and Vallet B. Role of endothelial dysfunction in sepsis mortality. Therapie 59 (2004) 31-40
43. Mutunga M., Fulton B., Bullock R., Batchelor A., Gascoigne A., Gillespie J.I., et al. Circulating endothelial cells in patients with septic shock. Am. J. Respir. Crit. Care Med. 163 (2001) 195-200
44. Megarbane B., Marchal P., Marfaing-Koka A., Belliard O., Jacobs F., Chary I., et al. Increased diffusion of soluble adhesion molecules in meningitis, severe sepsis and systemic inflammatory response without neurological infection is associated with intrathecal shedding in cases of meningitis. Intensive Care Med. 30 (2004) 867-874
45. Gando S., Kameue T., Matsuda N., Sawamura A., Hayakawa M., and Kato H. Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation 28 (2004) 237-244
46. Stefanec T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease?. Chest 117 (2000) 841-854
47. Bombeli T., Schwartz B.R., and Harlan J.M. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93 (1999) 3831-3838
48. Brodsky S.V., Malinowski K., Golightly M., Jesty J., and Goligorsky M.S. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 106 (2002) 2372-2378
49. Mezentsev A., Merks R.M., O'Riordan E., Chen J., Mendelev N., Goligorsky M.S., et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1106-H1114
50. Itakura Sumi Y., Ogura H., Tanaka H., Koh T., Fujita K., Fujimi S., et al. Paradoxical cytosqueleton and microparticle formation changes in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients. J. Trauma 55 (2003) 1125-1132
51. Jacoby R.C., Owings J.T., Holmes J., Battistella F.D., Gosselin R.C., and Paglieroni T.G. Platelet activation and function after trauma. J. Trauma 51 (2001) 639-647
52. Morel O., Jesel L., Hugel B., Douchet M.P., Zupan M., Chauvin M., et al. Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles. J. Thromb. Haemost. 1 (2003) 171-177
53. Fujimi S., Ogura H., Tanaka H., Koh T., Hosotsubo H., Nakamori Y., et al. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. J. Trauma 52 (2002) 443-448
54. Fujimi S., Ogura H., Tanaka H., Koh T., Hosotsubo H., Nakamori Y., et al. Increased production of leukocyte microparticles with enhanced expression of adhesion molecules from activated polymorphonuclear leukocytes in severely injured patients. J. Trauma 54 (2003) 114-119
55. Ogura H., Kawasaki T., Tanaka H., Koh T., Tanaka R., Ozeki Y., et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J. Trauma 50 (2001) 801-809
56. Morel N., Petit L., Morel O., Masson F., Freyssinet J.M., Bernard J.C., et al. Generation of procoagulant microparticles in cerebrospinal fluid and in blood after traumatic brain injury. Eur. J. Anesthesiol 21 S32 (2004) 97-98
57. Aras O., Shet A., Bach R.R., Hysjulien J.L., Slungaard A., Hebbel R.P., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103 (2004) 454-553
58. Utter G.H., Owings J.T., Jacoby R.C., Gosselin R.C., and Paglieroni T.G. Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J. Trauma 52 (2002) 1071-1077
59. Kobayashi S., Gando S., Morimoto Y., Nanzaki S., and Kemmotsu O. Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Surg. Today 31 (2001) 853-859
60. Gando S., Kameue T., Morimoto Y., Matsuda N., Hayakawa M., and Kemmotsu O. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit. Care (2002) 30
61. Gando S., Kameue T., Matsuda N., Hayakawa M., Ishitani T., Morimoto Y., et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb. Haemost. 88 (2002) 943-949
62. Gando S., Kameue T., Matsuda N., Hayakawa M., Morimoto Y., Ishitani T., et al. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb. Res. 109 (2003) 119-124
63. Joop K., Berckmans R.J., Nieuwland R., Berkhout J., Romijn F.P., Hack C.E., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb. Haemost. 85 (2001) 810-820
64. Rapaport S.I., and Rao L.V. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler. Thromb. 12 (1992) 1111-1121
65. Chen D., Giannopoulos K., Shiels P.G., Webster Z., McVey J.H., Kemball-Cook G., et al. Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium. Blood 104 (2004) 1344-1349
66. Lundahl T.H., Lindahl T.L., Fagerberg I.H., Egberg N., Bunescu A., and Larsson A. Activated platelets and impaired platelet function in intensive care patients analyzed by flow cytometry. Blood Coagul. Fibrinolysis 7 (1996) 218-220
67. Chamouard P., Desprez D., Hugel B., Kunzelmann C., Gidon-Jeangirard C., Lessard M., et al. Circulating cell derived microparticles in Crohn's disease. Dig. Dis. Sci. 50 (2005) 574-580
68. VanWijk M.J., Boer K., Berckmans R.J., Meijers J.C., van der Post J.A., Sturk A., et al. Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. Thromb. Haemost. 88 (2002) 415-420
69. Heloire F., Weill B., Weber S., and Batteux F. Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction. Thromb. Res. 110 (2003) 173-180
70. Barry O.P., Pratico D., Savani R.C., and FitzGerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J. Clin. Invest. 102 (1998) 136-144
71. Barry O.P., Pratico D., Lawson J.A., and FitzGerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 99 (1997) 2118-2127
72. Combes V., Taylor T.E., Juhan-Vague I., Mege J.L., Mwenechanya J., Tembo M., et al. Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA 291 (2004) 2542-2544
73. VanWijk M.J., VanBavel E., Sturk A., and Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc. Res. 59 (2003) 277-287
74. Combes V., Coltel N., Alibert M., van Eck M., Raymond C., Juhan-Vague I., et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J. Pathol. 166 (2005) 295-302
75. Nomura S., Kagawa H., Ozaki Y., Nagahama M., Yoshimura C., and Fukuhara S. Relationship between platelet activation and cytokines in systemic inflammatory response syndrome patients with hematological malignancies. Thromb. Res. 95 (1999) 205-213
76. Hess C., Sadallah S., Hefti A., Landmann R., and Schifferli J.A. Ectosomes released by human neutrophils are specialized functional units. J. Immunol. 163 (1999) 4564-4573
77. Martin S., Tesse A., Hugel B., Martinez M.C., Morel O., Freyssinet J.M., et al. Shed membranes particles from T lymphocytes impair endothelial function and regulate endothelial gene expression. Circulation 109 (2004) 1653-1659
78. Brodsky S.V., Zhang F., Nasjletti A., and Goligorsky M.S. Endothelium-derived microparticles impair endothelial function in vitro. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1910-H1915
79. Barry O.P., Kazanietz M.G., Pratico D., and FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 274 (1999) 7545-7556
80. Tesse A., Martinez M.C., Hugel B., Chalupsky K., Muller C.D., Meziani F., et al. Upregulation of proinflammatory proteins through NF-{kappa}B pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2522-2527 (Epub 2005 Oct 6)
81. Janiszewski M., Do Carmo A.O., Pedro M.A., Silva E., Knobel E., and Laurindo F.R. Platelet-derived exosomes of septic individuals possess proapototic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit. Care Med. 32 (2004) 818-825
82. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
83. Reinhart K., and Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit. Care Med. 29 (2001) S125
84. Panacek E.A., Marshall J.C., Albertson T.E., Johnson D.H., Johnson S., MacArthur R.D., et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. 32 (2004) 2173-2180
85. Nomura S., Kanazawa S., and Fukuhara S. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus. J. Diabetes Complications 17 (2003) 153-159
86. Rossig L., Hoffmann J., Hugel B., Mallat Z., Haase A., Freyssinet J.M., et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 104 (2001) 2182-2187
87. Rossig L., Haendeler J., Mallat Z., Hugel B., Freyssinet J.M., Tedgui A., et al. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J. Am. Coll. Cardiol. 36 (2000) 2081-2089
88. Nomura S., Shouzu A., Omoto S., Nishikawa M., and Iwasaka T. Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin. Appl. Thromb. Hemost. 10 (2004) 133-141
89. Sambola A., Osende J., Hathcock J., Degen M., Nemerson Y., Fuster V., et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107 (2003) 973-977
90. Dutton R.P., McCunn M., Hyder M., D'Angelo M., O'Connor J., Hess J.R., et al. Factor VIIa for correction of traumatic coagulopathy. J. Trauma 57 (2004) 709-718
91. Proulle V., Hugel B., Guillet B., Trichet C., Rafowicz A., Lambert T., et al. Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles. Thromb. Haemost. 91 (2004) 873-878
92. Hrachovinova I., Cambien B., Hafezi-Moghadam A., Kappelmayer J., Camphausen R.T., Widom A., et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat. Med. 9 (2003) 1020-1025